ECPR can be used as a salvage therapy for refractory cardiac arrest that does not respond to conventional Advanced Cardiac Life Support (ACLS) therapies. It is a time-critical and complex therapy that requires teamwork, clearly defined roles, and training to achieve successful outcomes.
ECPR can be deployed for both in-hospital and out-of-hospital cardiac arrest patients. For those patients that are considered candidates for ECPR, expected survival to hospital discharge for in-hospital cardiac arrest is around 40%, whilst out-of-hospital cardiac arrest survival salvaged with ECPR is about 20%. In survivors, the neurological outcomes generally fall into CPC categories 1 or 2. [1,2]